Biotech Investors & VC Firms

2475 firms in this list, with a median first check of $500K. 505 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
IN Invest-NL AGASBBBG23 people	88🔒	Amsterdam	NL	Series A–Growth	—	+ Add to CRM
MO Movac RTABATBA26 people · Leads rounds	88🔒	Auckland	NZ	Seed–Growth	$600K – $3M	+ Add to CRM
OM OMERS Private Equity Inc. AFCTGBJA26 people	88🔒	Toronto	CA	Growth	—	+ Add to CRM
LD LDC AUCHDADA13 people	88🔒	London	GB	Growth	$12.7M – $127M	+ Add to CRM
AG Agent Capital GVPNBPJG24 people · Leads rounds	88🔒	Waltham	US	Seed–Late Stage	—	+ Add to CRM
EM Emles Venture Partners JHJNJATR14 people · Follows rounds	88🔒	New York	US	Pre-Seed–Seed	—	+ Add to CRM
IN Innosphere Ventures MFABARBW38 people	88🔒	Fort Collins	US	Pre-Seed–Seed	—	+ Add to CRM
RE Relic 北貴大徹大亮黒裕29 people	88🔒	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
BL Blue Ocean Capital Group FYJCDTVC31 people	88🔒	Shenzhen	CN	Late Stage	—	+ Add to CRM
HC HCVC AHCAAFAR7 people · Leads rounds	88🔒	Paris	FR	Pre-Seed–Series A	$100K – $1M	+ Add to CRM
KI Kinnevik AAAHTSMJ20 people	88🔒	Stockholm	SE	Seed–Growth	—	+ Add to CRM
SW Swanlaab Venture Factory MKASASBB23 people · Leads rounds	88🔒	Madrid	ES	Seed–Series A	$540K – $3.2M	+ Add to CRM
IN Intrepid Growth Partners AAMMMSAW28 people	88🔒	Toronto	CA	Growth	—	+ Add to CRM
MI MIG Capital AG KSAKJKMK25 people	88🔒	Munich	DE	Seed–Series A	$1.1M – $10.8M	+ Add to CRM
BL Blackbird Bioventures CQCTMTAA39 people	88🔒	Baltimore	US	Pre-Seed–Seed	—	+ Add to CRM
IM Impact Fund Denmark ADABAWAF36 people	88🔒	Copenhagen	DK	Seed–Late Stage	$2.2M – $70.2M	+ Add to CRM
SH Shanghai Healthcare Capital 于任余傅45 people	88🔒	Shanghai	CN	Seed–Series B	—	+ Add to CRM
VE Verge HealthTech Fund CNEDFHJM24 people · Follows rounds	88🔒	Singapore	SG	Pre-Seed–Series A	$500K – $1.5M	+ Add to CRM
ZA ZAKA VC JKPZAPFO13 people	88🔒	San Francisco	US	Pre-Seed–Seed	—	+ Add to CRM
BO Bow Capital VRMSJCMR11 people · Follows rounds	88🔒	Menlo Park	US	Seed–Series A	$5M	+ Add to CRM
KA KAYA MRPMTOJJ17 people · Follows rounds	88🔒	Prague	CZ	Pre-Seed–Seed	$108K – $3.2M	+ Add to CRM
PE Peregrine Ventures ELBLLSRS14 people	88🔒	Or Yehuda	IL	Seed–Late Stage	$500K – $3M	+ Add to CRM
BE Better Ventures Central Llc RMWSCBLB6 people · Leads rounds	88🔒	Oakland	US	Pre-Seed–Series A	$500K – $1.5M	+ Add to CRM
VE Version One Ventures BWAATLG4 people · Leads rounds	88🔒	Vancouver	CA	Pre-Seed–Seed	$250K – $500K	+ Add to CRM

Invest-NL

AmsterdamSeries A–Growth

AGASBBBG23 people

Movac

AucklandSeed–Growth$600K – $3M

RTABATBA26 people

OMERS Private Equity Inc.

TorontoGrowth

AFCTGBJA26 people

LDC

LondonGrowth$12.7M – $127M

AUCHDADA13 people

Agent Capital

WalthamSeed–Late Stage

GVPNBPJG24 people

Emles Venture Partners

New YorkPre-Seed–Seed

JHJNJATR14 people

Innosphere Ventures

Fort CollinsPre-Seed–Seed

MFABARBW38 people

Relic

TokyoPre-Seed–Growth

北貴大徹大亮黒裕29 people

Blue Ocean Capital Group

ShenzhenLate Stage

FYJCDTVC31 people

HCVC

ParisPre-Seed–Series A$100K – $1M

AHCAAFAR7 people

Kinnevik

StockholmSeed–Growth

AAAHTSMJ20 people

Swanlaab Venture Factory

MadridSeed–Series A$540K – $3.2M

MKASASBB23 people

Intrepid Growth Partners

TorontoGrowth

AAMMMSAW28 people

MIG Capital AG

MunichSeed–Series A$1.1M – $10.8M

KSAKJKMK25 people

Blackbird Bioventures

BaltimorePre-Seed–Seed

CQCTMTAA39 people

Impact Fund Denmark

CopenhagenSeed–Late Stage$2.2M – $70.2M

ADABAWAF36 people

Shanghai Healthcare Capital

ShanghaiSeed–Series B

于任余傅45 people

Verge HealthTech Fund

SingaporePre-Seed–Series A$500K – $1.5M

CNEDFHJM24 people

ZAKA VC

San FranciscoPre-Seed–Seed

JKPZAPFO13 people

Bow Capital

Menlo ParkSeed–Series A$5M

VRMSJCMR11 people

KAYA

PraguePre-Seed–Seed$108K – $3.2M

MRPMTOJJ17 people

Peregrine Ventures

Or YehudaSeed–Late Stage$500K – $3M

ELBLLSRS14 people

Better Ventures Central Llc

OaklandPre-Seed–Series A$500K – $1.5M

RMWSCBLB6 people

Version One Ventures

VancouverPre-Seed–Seed$250K – $500K

BWAATLG4 people

Data sourced from public filings and firms' own websites — see our methodology.